Home  >   401k Directory   >   Alnylam Pharmaceuticals, Inc.
 
Company:
Alnylam Pharmaceuticals, Inc.
Plan:
Alnylam Pharmaceuticals, Inc. Savings & Investment Plan
 

Alnylam Pharmaceuticals, Inc.

82 Plan: Alnylam Pharmaceuticals, Inc. Savings & Investment Plan

 
 
82
12
76
88
0
10
20
30
40
50
60
70
80
90
100
For the average 401k participant, the 6 point difference between this plan's BrightScope Rating (82) and the top rated plan (88) could equate to:
[How is this calculated?]
5 additional years of work
Up to $17,900 in lost retirement savings.
The delay in retirement calculations apply solely to this defined contribution plan and do not take into account other retirement plans and programs offered by this employer.

 

Retirement Plan Description

Alnylam Pharmaceuticals, Inc. Savings & Investment Plan is a defined contribution plan with a 401k feature. This plan has a BrightScope Rating of 82. This plan is in the top 15% of plans for Salary Deferral. Alnylam Pharmaceuticals, Inc. Savings & Investment Plan currently has over 200 active participants and over $10.7M in plan assets.


 Investment Menu Statistics

No. of Investment Options
22
Plan Average: 20
Largest Funds in this 401k: based on % allocation of assets
1. Fidelity Advisor New Insights 12%
2. Alnylam Pharmaceuticals, Inc. Common Stock 9%
3. Columbia Acorn 7%

 Retirement Plan Details

Address 300 Third Street
3rd Floor
Cambridge, MA 02142 
Industry Professional, Scientific, and Technical Services
Administrator Michael Mason
Net Plan Assets $10,700,000
Total Participants 230
Avg Account Balance $51,000

 Compare Other Companies in Peer Group

XenoPort 78.7
ViroPharma 77.9
Physical Optics 77.1
Amtec 72.9
Cato Research Ltd. 72.2
Minneapolis Medical Research... 62.5

  Plan Service Providers

Recordkeeper Fidelity
Auditor McGladrey Wealth Management LLC